EXPERT OPINION ON EMERGING DRUGS

所属栏目:SCI期刊 热度:194

EXPERT OPINION ON EMERGING DRUGS

EXPERT OPINION ON EMERGING DRUGS

期刊周期:Quarterly
研究方向:医学
影响因子:3.23
通讯地址:INFORMA HEALTHCARE, TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON, ENGLAND, EC2A 4LQ
官网:http://www.tandfonline.com/loi/iemd20
审稿速度:>12周,或约稿

  中文简介

关于新兴药物的专家意见提供了最快速发展的药物类别和治疗领域的专家评估。由主要专家编写的新兴药物简介是权威的、全面的和最新的。新兴药物的专家意见是必不可少的阅读医药和学术科学家,研究规划,医药产品经理,临床意见领袖和医疗保健规划。制定关于新兴药物的专家意见的目的是对最重要的新兴药物技术提供专家评价。这些评估是根据它们对当前特定疾病管理的潜在影响。关于新兴药物的专家意见还包括关于新兴药物发展战略的论文,其目的是对最有希望的药物研究领域的商业和技术可行性提供一种可获得和独立的评估。

  英文简介

Expert Opinion on Emerging Drugs provides an expert assessment of the most rapidly advancing drug classes and therapeutic areas. Emerging Drugs profiles, prepared by leading experts, are authoritative, comprehensive and up-to date. Expert Opinion on Emerging Drugs is essential reading for pharmaceutical and academic scientists, research planners, pharmaceutical product mangers, clinical opinion leaders and healthcare planners. Expert Opinion on Emerging Drugs was devised with the intention of providing an expert evaluation of the most important emerging drug technologies. These are assessed in terms of their potential impact on the current management of specific diseases. Expert Opinion on Emerging Drugs also includes papers on Emerging Drug Development Strategies, which aim to provide an accessible and independent assessment of the commercial and technical viability of the most promising areas of drug research.

  近年期刊自引率趋势图

  JCR分区

JCR分区等级 JCR所属学科 分区 影响因子
Q2 PHARMACOLOGY & PHARMACY Q2 3.912

  近年期刊影响因子趋势图

  CiteScore数值

CiteScore SJR SNIP 学科类别 分区 排名 百分位
5.60 0.972 0.795 大类:Medicine 小类:Pharmacology (medical) Q2 66 / 255

74%

大类:Medicine 小类:Pharmacology Q2 110 / 303

63%

  相关医学SCI期刊推荐

SCI服务

搜论文知识网的海量职称论文范文仅供广大读者免费阅读使用! 冀ICP备15021333号-3